A REDEMPTION AND A ROTATION FOR U.S. EQUITY MARKETS. LIFE HERE AT BLOOMBERG HEADQUARTERS IN NEW YORK, I'M ROMAINE BOSTICK. KATIE: WE ARE KICKING OFF THE CLOSING BELL.IT IS A FRIDAY AND STOCKS ARE GREEN. HIGHER BY ABOUT 1.7% PERCENT. BIG TECH SLIGHTLY BETTER, BUT LOOKS PEDESTRIAN COMPARED TO WHAT WE ARE SEEING IN THE SMALL CAPS RIGHT NOW.WHAT A BOUNCE BACK FOR THE LITTLE GUYS, HIGHER BY 3.4%. IT HAS BEEN A BIT OF A BRUTAL WEEK, SO A BIT OF GREEN TO FINISH OUT THE WEEK. LET'S TALK ABOUT BITCOIN.WE WERE ABOUT ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nasdaq will hold its 2026 Investor Day at the company’s Global Headquarters in Times Square, New York. Due to limited capacity, in-person attendance is by invitation only. When: Wednesday, February 25, 2026 8:00 AM – 12:30 PM ETWhere:Webcast registration link: https://edge.media-server.com/mmc/p/u69c26de The agenda, slide presentation and a live webcast will be available on the day of the event on Nasdaq’s IR website: http://ir.nasdaq.com. A replay will be avai ...

纳斯达克公司股价跌幅扩大至逾3.5%。 来源：滚动播报 ...

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2026 on its Investor Relations website. A data sheet showing this information can be found at: https://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world’s economies. We architect the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by ...

Core Viewpoint - The stock rally has lost momentum, with the S&P 500 trading at the same price as last October, indicating a stagnation in market performance [1]. Group 1 - The S&P 500 is currently at the same price level as it was in October of the previous year, suggesting a lack of upward movement in the market [1]. - The Nasdaq has also shown signs of stagnation, reflecting a broader trend in the stock market [1]. - The investment approach focuses on long-term strategies, utilizing low-risk ETFs and CEFs to navigate the current market conditions [1].

Core Insights - Nasdaq has been selected by Osaka Exchange (OSE) to provide advanced Eqlipse Trading and Market Surveillance technology platforms, marking a significant step in OSE's modernization efforts and enhancing Japan's competitiveness in the global derivatives market [1][2][3] Group 1: Technology Partnership - The partnership with Nasdaq is expected to strengthen OSE's derivatives trading foundation, providing a safer and more efficient trading environment for all market stakeholders [2] - Nasdaq's technology will enable OSE to rapidly deploy new products and services, efficiently manage volume fluctuations, and maintain high performance standards [2][5] Group 2: Market Integrity and Performance - The integration of Nasdaq Market Surveillance technology will enhance OSE's market integrity framework, utilizing advanced analytics and AI to detect potential market abuse [6] - The Eqlipse Trading platform will support multi-asset trading with ultra-low latency, providing robust risk management tools and market-standard APIs [5] Group 3: Commitment to Modernization - OSE's modernization program reflects a commitment to world-class market infrastructure that adapts to evolving market dynamics while ensuring operational excellence [4][8] - Nasdaq's long-standing partnership with Japan's financial services ecosystem underscores its role in supporting the modernization and growth of Japan's capital markets [7][8] Group 4: Global Technology Leadership - Nasdaq's technology is utilized by major global financial institutions, including systematically important banks and stock exchanges, showcasing its leadership in market infrastructure [10]

Core Viewpoint - Adial Pharmaceuticals, Inc. will implement a 1-for-25 reverse stock split to comply with Nasdaq's minimum bid price requirement and enhance its capital markets profile [1][3][4] Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 27.8 million to about 1.1 million, while maintaining the ownership percentage of each shareholder [2] - The reverse stock split will take effect on February 5, 2026, at 11:59 p.m. Eastern Time, with trading on a split-adjusted basis starting February 6, 2026 [1][2] - There will be no change to the total number of authorized shares as per the Company's Certificate of Incorporation [2] Group 2: Strategic Intentions - The reverse stock split aims to bring the Company into compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share [3] - The action is expected to make the bid price more attractive to a wider range of institutional and retail investors [3][4] - The Company remains optimistic about its future and is focused on advancing its lead product, AD04, for the treatment of Alcohol Use Disorder [4][5] Group 3: Company Overview - Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for addiction and related disorders [5] - The lead investigational drug, AD04, is a genetically targeted serotonin-3 receptor antagonist aimed at treating Alcohol Use Disorder in heavy drinking patients [5] - The Company plans to conduct a new Phase 3 clinical trial program for AD04, which has shown promising results in reducing drinking without significant safety concerns [5]

January was for builders.No matter the conditions, we never learned how to stop.Here is a long, but incomplete list on what was shipped on Avalanche this month.Comment below if we missed anything:1. The first AVAX ETF, $VAVX from @vaneck_us, went live on @Nasdaq2. The Build Games began, a competition in which builders can create any type of app on Avalanche and win a share of $1,000,000 in prizes.3. Retro-9000 C-Chain round dropped, incentivizing apps that organically burn AVAX on the C-chain.4. The Avalanc ...

Group 1 - Nasdaq, Inc. (NDAQ) has achieved a total return of almost 500% over the past 10 years, outperforming many other companies in the market [1] - The focus is on identifying companies with exceptional quality that can reinvest capital for impressive returns, aiming for a long-term capital compounding capability [1] - A conservative investment strategy is primarily adopted, with occasional pursuit of opportunities that present a favorable risk-reward ratio [1]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]